Some embodiments described herein relate generally to methods and devices for facilitating the insertion of an implant between bone portions.
Some embodiments described herein relate generally to methods and implants for fusing bone, for example, fusing vertebrae by securing the articular processes of the vertebrae. Other embodiments described herein relate to augmentation and restoration of vertebral facet joints affected by degeneration and the surgical method and devices for implanting these devices in the spine
Traumatic, inflammatory, and degenerative disorders of the spine can lead to severe pain and loss of mobility. One source of back and spine pain is related to degeneration of the facets of the spine or facet arthritis. Bony contact or grinding of degenerated facet joint surfaces can play a role in some pain syndromes. While many technological advances have focused on the intervertebral disc and artificial replacement or repair of the intervertebral disc, little advancement in facet repair has been made. Facet joint and disc degeneration frequently occur together. Thus, a need exists to address the clinical concerns raised by degenerative facet joints.
The current standard of care to address the degenerative problems with the facet joints is to fuse the two adjacent vertebrae. By performing this surgical procedure, the relative motion between the two adjacent vertebrae is stopped, thus stopping motion of the facets and any potential pain generated as a result thereof. Procedures to fuse two adjacent vertebrae often involve fixation and/or stabilization of the two adjacent vertebrae until the two adjacent vertebrae fuse. Commonly owned U.S. Patent Publications 2012/0221049 (U.S. application Ser. No. 13/403,698, filed Feb. 23, 2012) and U.S. Pat. No. 8,740,949 (U.S. application Ser. No. 13/033,791, filed Feb. 24, 2011) describe methods for stabilizing two bone portions by extending a flexible fastening band through a lumen in two bone portions. The flexible fastening band can be advanced through a fastener until the two bone portions are stabilized. In one embodiment, the first bone portion is the articular process of a first vertebrae and the second bone portion is an articular process of a second vertebra. As described in these applications, in certain embodiments it is useful to dispose prosthesis (e.g., an allograft, metallic implant, etc.) between the first and second bone portions before stabilizing the two bone portions.
Commonly owned U.S. Pat. No. 7,846,183 (U.S. application Ser. No. 10/865,073, filed Jun. 10, 2004) describes a method in which the facet joint is restored by inserting a prosthesis between bone portions, such as a facet joint. Such a procedure can alleviate the bone on bone contact that is common in degenerative facet joints and often the source of pain generation, while allowing relative motion between the facets to continue post-operatively.
Injuries and/or surgical procedure on and/or effecting other bones can also result in the desire to fixate and/or stabilize a bone until the bone, or bone portions, can fuse, for example, to stabilize a sternum after heart surgery, to stabilize a rib after a break, etc. Current procedures to fixate and/or stabilize adjacent vertebrae and/or other bones can be slow and/or complex.
Accordingly, a need exists for an apparatus and a procedure to quickly and/or easily stabilize and/or fixate a bone.
In some embodiments, a method of placing an implant between a first bone portion and a second bone portion is provided. The method can include the step of forming a lumen in a first bone portion. The method can include the step of forming a lumen in a second bone portion. The method can include the step of inserting a trial implant between the first bone portion and the second bone portion. The method can include the step of inserting a portion of a flexible member through the lumen in the first bone portion, through the trial implant, and through the lumen in the second bone portion. The method can include the step of withdrawing the trial implant and the flexible member from between the first and second bone portions. The method can include the step of coupling an implant with the flexible member. The method can include the step of advancing the implant between the first and second bone portions.
In some embodiments, the first bone portion is a first articular process and the second bone portion is a second articular process. The method can include the step of tying ends of the flexible member together. In some embodiments, the step of coupling an implant with the flexible member can include the step of passing the flexible member through a hole in the implant. In some embodiments, the step of coupling an implant with the flexible member can include the step of passing the flexible member through a slot extending from the edge of the implant. In some embodiments, the implant comprises an allograft. The method can include the step of sizing the implant to fit into the joint space between the first bone portion and the second bone portion. In some embodiments, the step of forming a lumen in a first bone portion can include drilling a hole. In some embodiments, the step of withdrawing the flexible member from between the first and second bone portion can include bringing the flexible member out at a joint line. The method can include the step of inserting the trial implant between the first bone portion and the second bone portion before forming a lumen in the first bone portion and forming a lumen in the second bone portion. In some embodiments, the step of advancing the implant between the first and second bone portions can include applying tension to both ends of the flexible member. The method can include the step of inserting a flexible retention member through the first bone portion, the implant, and the second bone portion and using the flexible retention member to secure the first bone portions and the second bone portions. In some embodiments, the flexible retention member comprises a ratchet.
In some embodiments, a method of placing an implant in a spine facet joint is provided. The method can include the step of drilling a hole across the facet joint. The method can include the step of inserting a trial implant in the joint space. The method can include the step of passing a flexible member through the hole and across the facet joint. The method can include the step of withdrawing the flexible member out of the facet joint at a joint line by withdrawing the trial implant. The method can include the step of coupling an implant with the flexible member. The method can include the step of pulling the ends of the flexible member to reduce implant into the joint space. In some embodiments, implant comprises an allograft. The method can include the step of sizing the implant to fit into the joint space.
In some embodiments, an implant for placement between a first bone portion and a second bone portion is provided. The implant can include a body that is sized to fit in the facet joint of a spine. In some embodiments, the body formed from artificial materials, allograft or a combination thereof. The implant can include the body having a slot extending from an edge of the body to a hole. In some embodiments, the slot and the hole are configured to slidingly accept a flexible member.
In some embodiments, a kit for placement of an implant between two bone portions is provided. The kit can include a trial member with an opening configured to engage a flexible member. The kit can include a drill configured to form an opening between two bone portions. In some embodiments, the drill is configured to drill a hole when the trial member inserted between the two bone portions. The kit can include an implant with an opening configured to engage the flexible member. The kit can include a flexible member. The kit can include a flexible fastening band through with fastener. In some embodiments, the implant comprises an allograft.
For purposes of summarizing the invention and the advantages achieved over the prior art, certain objects and advantages of the invention have been described herein above. Of course, it is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught or suggested herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
All of these embodiments are intended to be within the scope of the invention herein disclosed. These and other embodiments will become readily apparent to those skilled in the art from the following detailed description of the preferred embodiments having reference to the attached figures, the invention not being limited to any particular preferred embodiment(s) disclosed.
These and other features, aspects, and advantages of the invention disclosed herein are described below with reference to the drawings of preferred embodiments, which are intended to illustrate and not to limit the invention.
Although certain preferred embodiments and examples are disclosed below, it will be understood by those in the art that the invention extends beyond the specifically disclosed embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the invention herein disclosed should not be limited by the particular disclosed embodiments described below.
As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “an implant” is intended to mean a single implant or a combination of implants. As used in this specification, a substance can include any biologic and/or chemical substance, including, but not limited to, medicine, adhesives, etc. While exemplary references are made with respect to vertebra, in some embodiments another bone or portions of bones can be involved. While specific reference may be made to a specific vertebra and/or subset and/or grouping of vertebrae, it is understood that any vertebra and/or subset and/or grouping, or combination of vertebrae can be used.
As shown in
The orientation of the facet joints vary, depending on the level of the vertebral column. In the C1 and C2 vertebrae, for example the facet joints are parallel to the transverse plane.
In addition to guiding movement of the vertebrae, the facet joints also contribute to the load-bearing ability of the vertebral column. One study by King et al. Mechanism of Spinal Injury Due to Caudocephalad Acceleration, Orthop. Clin. North Am., 6:19 1975, found facet joint load-bearing as high as 30% in some positions of the vertebral column. The facet joints may also play a role in resisting shear stresses between the vertebrae. Over time, these forces acting on the facet joints can cause degeneration and arthritis.
Flexible Fastening Band
In some embodiments described herein, a flexible fastening band can be used to stabilize and/or fixate a first vertebra to a second vertebra to reduce the pain, to reduce further degradation of a spine, or of a specific vertebra of a spine, and/or until the first vertebra and the second vertebra have fused.
Proximal end portion 142 is configured to pass through a lumen formed through a vertebra and a lumen formed through an adjacent vertebra, and to pass through fastening mechanism 150 of the distal end portion 148. In some embodiments, proximal end portion 142 can be shaped to incrcase the case of inserting proximal end portion 142 into fastening mechanism 150, e.g., proximal end portion 142 can be tapered, rounded, and/or angled, etc., to reduce at least a portion of a cross-sectional area of proximal end portion 142.
First portion 144 can extend for a length between proximal end portion 142 and second portion 146, and can have a substantially uniform shape. The first portion 144 can have, for example, a substantially cuboidal shape, or a substantially cylindrical shape. In some embodiments, the length of first portion 144 can be more than twice the length of second portion 146. In some embodiments, the cross-sectional area of the first portion 144 can be smaller than the cross-sectional area of the second portion 146. In some embodiments, the cross-sectional area of first portion 144 can be less than a cross-sectional area of a lumen defined by the fastening mechanism 150. First portion 144 can include a gear rack (not shown in
Second portion 146 can have a length between first portion 144 and distal end portion 148, and can include a substantially uniform shape. In embodiments including the third portion, second portion 146 can have a length between first portion 144 and the third portion. Second portion 146 can have, for example, a substantially cuboidal shape or a substantially cylindrical shape. First portion 144 and second portion 146 can have the same or different shapes, e.g., first portion 144 and second portion 146 can both be substantially cuboidal (see, e.g., band 240 in
Distal end portion 148 includes a fastening mechanism 150 configured to accept at least a portion of proximal end portion 142, first portion 144, and/or second portion 146. In some embodiments, distal end portion 148, second portion 146, first portion 144, and proximal end portion 142 can be monolithically formed. Fastening mechanism 150 includes a lumen (not shown in
In some embodiments, at least one of distal end portion 148, second portion 146, first portion 144, and proximal end portion 142 can be formed separately from the other(s) of distal end portion 148, second portion 146, first portion 144, and proximal end portion 142. Said another way, and by way of example, distal end portion 148, first portion 144, and proximal end portion 142 can be monolithically formed together, while second portion 146 can be separately formed. In this manner, band 140 can include an initial second portion 146 configured to be replaced and/or covered with a replacement second portion 146. By way of a first example, initial second portion 146 can be monolithically formed with first portion 144 and replacement second portion 146 can be slideably disposed over initial second portion 146. By way of a second example, initial second portion 146 can be separately formed from first portion 144, can be removed from band 140, and replacement second portion 146 can be slideably disposed over first portion 144. By way of a third example, initial second portion 146 can be separately or monolithically formed from first portion 144, and replacement second portion 146 can be slideably disposed over first portion 144 and initial second portion 146. In some embodiments, initial second portion 146 and replacement second portion 146 can have the same shape, e.g., initial second portion 146 can include a substantially cylindrical shape and replacement second portion 146 can include a substantially cylindrical shape. In some embodiments, initial second portion 146 and replacement second portion 146 can have different shapes, e.g., initial second portion 146 can include a substantially cuboidal shape and replacement second portion 146 can include a substantially cylindrical shape.
In some embodiments, the shape of first portion 144 and the shape of second portion 146 can be determined based on the shape of an artificial lumen formed through an articular process of a vertebra. By way of example, if the shape of the artificial lumen is cuboidal, the shape of the first portion 144 and the shape of the second portion 146 can be cuboidal to allow the first portion 144 and the second portion 146 to slideably advance through the artificial lumen. By way of a second example, if the shape of the artificial lumen is cylindrical, the shape of the first portion 144 and the shape of the second portion 146 can be either cuboidal or cylindrical. Continuing with the second example, the shape of the first portion 144 can be cuboidal to allow the first portion 144 to advance easily through the artificial lumen, while the shape of the second portion 146 can be cylindrical to allow the second portion 146 to fit more tightly within the artificial lumen as compared to a cuboidal shape.
In some embodiments, the shape of the first portion 144 and the shape of the second portion 146 can be determined based on characteristics of the bone or bone portion against which the first portion 144 and the second portion 146 may contact. By way of example, while first portion 144 and/or second portion 146 can be substantially cuboidal, edges of the first portion 144 and/or the second portion 146 can be rounded, partially rounded, and/or otherwise shaped to compliment the shape of a bone or bone portion, and/or to reduce digging or grinding into the bone or bone portion. In this manner, use of band 140 may cause little or no damage to the bone or bone portions contacted by band 140.
In some embodiments, band 140 can include a third portion (not shown in
While each of first portion 144, second portion 146, and the third portion can be a substantially uniform shape, in some embodiments any one of first portion 144, second portion 146, and the third portion can include a transition portion to transition band 140 from a first substantially uniform shape to a second substantially uniform shape. By way of example, in some embodiments, first portion 144 and the third portion can be substantially cuboidal and second portion 146 can be substantially cylindrical. In this example, second portion 146 can include an angled, conical, or other shaped transition portion.
Each of band 240 and band 340 can be similar to band 140 described above and can include similar components. By way of example, band 240 includes a proximal end portion 242, a first portion 244, a second portion 246, and a distal end portion 248 including a fastening mechanism 250, and band 340 includes a proximal end portion (not shown in
Additional description, modified and alternative embodiments of the flexible fastening band and methods of installing and using such a band can be found in U.S. Pat. No. 8,740,949 (U.S. application Ser. No. 13/033,791, filed Feb. 24, 2011) and U.S. Patent Publication 2012/0221049 (U.S. application Ser. No. 13/403,698, filed Feb. 23, 2012), which are hereby bodily incorporated by reference.
Method and Apparatus for Placement of Device Between Bone Portions
Step 1002 can include forming a lumen across two bone portions. A drill or other device (e.g., tissue punch or reamer) can be used to form a lumen across two bone portions. In some embodiments, the two bone portions are facets. This step can involve forming a lumen in superior articular process SAP2A of vertebra V2 and inferior articular process IAP1A of vertebra V1. For example, the drill can be used to form the lumen in a facet of superior articular process SAP2A of vertebra V2 and form the lumen in a facet of inferior articular process IAP of vertebra V1. Methods and devices for forming lumens in vertebra are described in U.S. Pat. No. 7,846,183 (application Ser. No. 10/865,073, filed Jun. 10, 2004) and U.S. Patent Publication No. 2011/0040301 (application Ser. No. 12/859,009, filed Aug. 18, 2010), which are hereby bodily incorporated by reference herein. A flexible member, such as a suture, can be positioned within the cannula and can be advanced through the cannula until the proximal end portion of the flexible member is positioned near the lumen of superior articular process SAP2A of vertebra V2.
Step 1004 can include inserting a portion of the flexible member through the lumen and across the two bone portions. The flexible member can be inserted into and through the lumen of the first bone portion. The flexible member can be inserted into and through the lumen of the second bone portion. The flexible member has two ends. In some embodiments, the first end is threaded consecutively through the first bone portion and through the second bone portion. After the threading, one end of the flexible member extends beyond the first bone portion and the other end of the flexible member extends beyond the second bone portion. In some embodiments, the two bone portions are facets. The proximal end portion of the flexile member can be inserted into the lumen of superior articular process SAP2A of vertebra V2 and through the lumen of inferior articular process IAP1A of vertebra V1. After the threading, one end of the flexible member extends beyond the superior articular process and the other end of the flexible member extends beyond the inferior articular process.
Step 1006 can include coupling a portion of the flexible member extending across to bone portions to the implant. This step may include withdrawing a portion of the flexible member out of the joint. In some embodiments, the flexible member is coupled to a trial implant when the flexible member is withdrawn. This step can include bringing the flexible member out at a joint line. In some embodiments, the bone portions are facets. This step may include withdrawing a portion of the flexible member from the facet joint. An implant is coupled to the flexible member. In some embodiments, the implant can be coupled to the flexible member by sliding the implant onto the flexible member. The implant can include an engagement feature extending from the edge of the implant to the center of the implant. The engagement feature may be slot connected to an aperture. The slot may be linear or non-linear. A non-linear slot may prevent accidental disengagement between the implant and the flexible member. During step 1006, the flexible member remains threaded through the lumen in the first bone portion and the lumen of the second bone portion.
Step 1008 can include inserting the implant into the space between the bone portions. In some embodiments, the implant is inserted into the joint space between facet joints. In some embodiments, tension is applied to both ends of flexible member. The tension takes up slack in the flexible member, urging the implant into the joint space. Tension can be applied until the shortest distance of the flexible member is between the first bone portion and the second bone portion. The implant can be positioned such that the aperture of the implant forms a path between the first bone portion and the second bone portion.
With the implant between two bone portion, for example within the facet joint, a band can inserted into and through the lumen in first bone portion, into and through the aperture in the implant, and into and through the lumen in the second bone portion. The band or other retaining member can be advanced through a fastening mechanism until the two bone portions are stabilized as described in U.S. Patent Publication No. 2012/0221049 (U.S. application Ser. No. 13/403,698, filed Feb. 23, 2012) and U.S. Pat. No. 8,740,949 (U.S. application Ser. No. 13/033,791, filed Feb. 24, 2011). In such embodiments, the band can extend through the implant. The flexible member can be cut to reduce the size the flexible member. In some embodiments, the ends of the flexible member can be tied to secure the implant within the joint.
The trial member 500 can include a notch 512 on the proximal end of the shaft 504 to secure the trial member 500 to a tool 400 via a retention member. The trial implant 502 can comprise a disk-like member having an aperture 508. The trial implant 502 can have a curved or cupped shape to facilitate positioning between the articular processes 20, 22. In some embodiments, the trial implant 502 may have different shapes, sizes and thicknesses for use with different sized vertebra.
Some embodiments comprise tools and methods for creating holes or lumens through one or more bone portions such as the articular processes 20, 22 of the vertebra to facilitate implantation of the implant 40. In some embodiments, the holes or lumens have a curved or non-linear configuration. The curved or non-linear configuration allows relatively greater penetration through the thicker portions of the articular process(es) and therefore the articular process(es) may be less likely to fracture during formation of the hole or lumen. While various instruments have been proposed for drilling into and through bone, including for example, the curved drills described in U.S. Pat. Nos. 5,700,265, 6,419,678, and 6,607,530, herein incorporated by reference in their entirety, the subject tool offers the benefits of lumen formation through the articular processes within the limited surgical access available about the vertebra. The devices described herein may utilize one or more curved punch members or curved drills that rotate about an axis that is transverse to the movement plane of the curved punch or curved drill member. Unlike traditional orthopedic procedures that require unimpeded access to the surgical site due to the longitudinally-oriented surgical tools, the curved punch or curved drill members also permit access using a limited space or cavity around the articular processes. As used herein, the terms “lumen-forming” and “lumen formation” refer to the creation of a hole, passageway or indentation generally such as by, for example, piercing, punching, boring, puncturing, or drilling.
The lumen-forming arm 410 can be slideably contained within the shaft 402 and the arm guide 406. The lumen-forming arm 410 can be moved between an advanced configuration, and a retracted configuration, by a proximal actuator 422 that moves the lumen-forming arm 410 axially along the shaft 402 of the tool 400. In the embodiment shown, manipulation of the actuator 422 causes a longitudinal movement of the lumen-forming arm 410. The lumen-forming arm 410 can be straight or curved or a combination of these shapes. The lumen-forming arm 410 may be stiff, bendable, or partially stiff and partially bendable.
In some embodiments, the lumen-forming arm 410 can be sized to be able to pass through the articular processes 20, 22 of the spine and the resulting hole is sized for a flexible member 30 and/or band 140, 240 to be inserted. The lumen-forming arm 410 can have a diameter in the range of about 1 mm to 5 mm, preferably about 2 mm to 4 mm, and most preferably about 3 mm. At an end of the rotating drill bit 412 can be a drill bit tip 413 (not shown) with a cutting surface for creating the lumen in the facets.
A target member 408 having a target plate 414 can be connected to the frame 418. The target plate 414 is in the path of travel of the lumen forming arm 410 and thus the position of the target plate 414 against an articular process 22 can provide indication to the user of where the lumen forming arm 410 will emerge from the articular processes 20, 22 during the drilling procedure. The target member 408 can advantageously help the user avoid neural or other structures in and around the articular process 22 by visualizing and understanding the trajectory of the lumen forming arm 410 through the articular processes 20, 22. In some embodiments, the target member 408 can provide some stabilization of the articular processes 20, 22 as the lumen forming arm 410 passes or cuts through the bone.
The tool 400 can further comprise a trial member 500 that can be coupled to the handle 404. The trial member 500 can comprise a shaft 504 that is connected by retention member to the tool 400. Preferably, the retention member allows the trial member 500 to be detached from and attached to the facet drill tool 400 with case. With the trial member 500 in place and the trial implant 502 in the facet joint 28 as shown in
The tool 400 may be used by positioning the anchor portion 426 of an arm guide 406 against one bone portion such as the articular process 20 and positioning the target plate 414 against another bone portion, such as the articular process 22. The tool 400 can be rotated axially relative to the trial member 500 to adjust for variations in the native anatomy of the patient. The surgeon may select a particular rotational and/or angular approach to the surgical site, depending upon the particular anatomy of the patient, the extent and location of damage or injury, prior surgery, and other factors known in the art. Additional embodiments and method related to drilling holes in bones can be found in U.S. Patent Publication No. 2011/0040301 (application Ser. No. 12/859,009, filed Aug. 18, 2010).
In some embodiments, the trial member 500 can rotate about its longitudinal axis while coupled to the tool 400 to accommodate variations in the shapes and positions of the articular processes 20, 22. The aperture 508 can be sufficiently large to allow the lumen-forming arm 410 to pass through the aperture 508 even when the trial member 500 is at an angle to the lumen-forming arm 410.
Alternative embodiments and methods of use of various tools are described in commonly owned US. Patent Publication No. 2011/0040301 (U.S. application Ser. No. 12/859,009, filed Aug. 18, 2010), which is incorporated by reference. Accordingly, the device and methods herein can be combined with the devices and methods disclosed in other applications incorporated by references.
As shown in
As shown in
As shown in
The implant 40 comprises a body with a least two faces, a first face adapted to contact a first bone such as the articular surface of one facet of the facet joint and a second face adapted to contact a second bone such as the articular surface of the other facet. The aperture 48 can be sized and configured to accept a retaining member, such as the retaining members described in U.S. Pat. No. 7,846,183 (U.S. application Ser. No. 10/865,073, filed Jun. 10, 2004). The aperture 48 can be sized and configured to accept a band, such as the bands described herein and in U.S. Publication No. 2012/0221060 (U.S. application Ser. No. 13/033,791, filed Feb. 24, 2011).
In some embodiments, the implant 40 has a generally circular profile and is sized to fit generally within the joint capsule of the facet joint 28. In some embodiments, the implant 40 can be, for example, substantially disc shaped. In other embodiment of the invention, the implant 40 can have any of a variety of profiles, including but not limited to square, rectangle, elliptical, oval, star, polygon or combination thereof. In some embodiments, an implant 40 having the desired shape is selected from an array of implants after radiographic visualization of the articular processes and/or by radio-contract injection into the facet joint to visualize the joint capsule.
In some embodiments, the implant 40 has a diameter of about 4 mm to about 30 mm. In another embodiment, the implant 40 has a diameter of about 5 mm to about 25 mm. In still another embodiment, the implant 40 has a diameter of about 10 mm to about 20 mm. In some embodiments, the implant 40 has a cross-sectional area of about 10 mm2 to about 700 mm2. In another embodiment, the implant 40 has a cross-sectional area of about 25 mm2 to about 500 mm2. In still another embodiment, the implant 40 has a cross-sectional area of about 20 mm2 to about 400 mm2, and preferably about 25 mm2 to about 100 mm2.
The implant 40 has a thickness generally equal to about the anatomic spacing between two facets of a facet joint. In some embodiments, the implant 40 generally has a thickness within the range of about 0.5 mm to about 3.0 mm. In some embodiments, the implant 40 has a thickness of about 1 mm to about 2 mm. In some embodiments, the implant 40 has a thickness of about 0.5 mm to about 1.5 mm. In some embodiments, the thickness of the implant 40 is non-uniform within the same implant. For example, the thickness of the implant 40 can be incrcased around the entire outer edge, along at least one and, as illustrated, both faces. In some embodiments, only a portion of the edge on one face of the implant 40 has a thickness that is greater than the thickness of a central region, and, optionally, also thicker than the typical anatomic spacing between two facets of a facet joint. An incrcased edge thickness may resist lateral displacement of the prosthesis out of the facet joint.
In some embodiments of the invention, the implant 40 is configured to provide an improved fit with the articular process and/or joint capsule. For example, the implant 40 can have a bend, angle or curve to generally match the natural shape of an articular facet. The implant 40 may be rigid with a preformed bend. Alternatively, the implant 40 may be sufficiently malleable that it will conform post implantation to the unique configuration of the adjacent facet face. In certain embodiments, the implant 40 is configured to be implanted between the articular processes and/or within the joint capsule of the facet joint, without securing of the implant to any bony structures. Such embodiments can thus be used without invasion or disruption of the vertebral bone and/or structure, thereby maintaining the integrity of the vertebral bone and/or structure.
The implant 40 can be similar to, and have similar features to the embodiments of the prosthesis shown and described in commonly owned U.S. Pat. No. 7,846,183 (application Ser. No. 10/865,073, filed Jun. 10, 2004), which is incorporated herein by reference in its entirety. The implant 40 can be implanted and deployed to restore the space between facets of a superior articular process of a first vertebra and an inferior articular process of an adjacent vertebra. As described herein, the implant 40 can be deployed to help stabilize adjacent bone portions, such as adjacent facets of a facet joint. A porous surface can allow bone to grow into or attach to the surface of the implant, thus securing the implant to the bone. In one embodiment, an adhesive or sealant, such as a cyanoacrylate, polymethylmethacrylate, or other adhesive known in the art, is used to bond one face of the implant to an articular surface.
The implant can include a first side and a second side. The first side and/or the second side can be, for example, convex, concave, or flat. The first side of the implant can be concave, convex, or flat, and the second side of the implant can be concave, convex, or flat. For example, the first side can be concave and the second side concave, the first side can be concave and the second side convex, etc.
In some embodiments, at least a portion of the implant 40 can be formed of allograft. In some embodiments, at least a portion of the implant 40 can be formed of artificial materials, such as, for example, titanium or PEEK. In some embodiments, the implant 40 can be deployed to deliver and/or relcase a substance. In some embodiments, the substance can have therapeutic properties, for example, a medication. In some embodiments, the substance is an adhesive. The implant 40 can include the same materials as the flexible band, describe herein. In some embodiments, the implant 40 can incrcase the stability of a vertebra and/or the flexible band, describe herein.
As described in these applications, US. Patent Publication Nos. 2012/0221049 (U.S. application Ser. No. 13/403,698, filed Feb. 23, 2012) and 2012/0221060 (U.S. application Ser. No. 13/033,791, filed Feb. 24, 2011) in certain embodiments it is useful to dispose the implant 40 between the first and second bone portions before stabilizing the two bone portions and/or performing other procedures. Certain aspects of the described herein involve facilitating the insertion of the implant 40 between the bone portions. Accordingly, the device as methods herein can be combined with the devices and methods disclosed in other applications incorporated by references.
As shown in
In some embodiments, a method of placing an implant into a facet joint of the spine is provided. The method can include the step of forming a hole across the facet joint. The method can include the step of passing a flexible member through the hole and across the facet joint. The method can include the step of bringing the flexible member out of the facet joint. The method can include the step of coupling an implant to the flexible member. The method can include the step of tightening the flexible member to reduce into the implant into a joint space.
The method can include the step of cutting the flexible member. The method can include the step of tying cut ends of the flexible member together. In some embodiments, the flexible member is a suture. In some embodiments, the implant includes a hole for receiving the flexible member. In some embodiments, the implant includes a slot for receiving the flexible member. In some embodiments, the implant includes allograft or an artificial material. In some embodiments, the implant is sized to fit into the joint space. In some embodiments, the step of forming a hole across the facet joint comprises drilling a hole. In some embodiments, the step of bringing the flexible member out of the facet joint comprises bringing the flexible member out at a joint line. The method can include the step of inserting a trial implant into the joint space before forming a hole across the facet joint. The method can include the step of withdrawing the trial implant out of the joint space to bring the flexible member out of the facet joint. The method can include the step of inserting a flexible retention member through the facet joint and the implant and using the flexible retention member to secure the facet joint.
In some embodiments, a method of placing an implant in a spine facet joint is provided. The method can include the step of drilling a hole across the facet joint. The method can include the step of removing the drill. The method can include the step of leaving behind a trial/targeting device in the joint space. The method can include the step of passing a suture through the hole and across the facet joint. The method can include the step of bringing the suture out of the facet joint at a joint line by removing the trial/targeting device. The method can include the step of removing the suture from the trial/targeting device by passing it through a slot in the trial/targeting device. The method can include the step of placing an implant with a hole and slot over the suture. The method can include the step of pulling the suture tight to reduce implant into the joint space. In some embodiments, the implant comprises artificial material and/or allograft. In some embodiments, the implant is configured and sized to fit into the joint space.
In some embodiments, a device for placement in a spine facet joint is provided. The device can include a body that is sized to fit in the facet joint of a spine. In some embodiments, the body is formed from artificial materials, allograft or a combination thereof. In some embodiments, the body has a hole for receiving a suture or flexible fixation member. In some embodiments, the body has a slot so that it can be placed over a portion of the suture or flexible fixation member.
In some embodiments, a kit for placement of an implant into a spine facet joint is provided. The kit can include a trial member with an opening. The kit can include a drill configured to form an opening between two bone portions and the trial member inserted between the two bone portions. The kit can include an implant with an opening. The kit can include a flexible member. The kit can include a flexible fastening band through with fastener. In some embodiments, the implant comprises an allograft.
It should be appreciated that the methods and devices described herein for placing an implant into a joint or between two bone portions are not limited to fusion applications and/or the fusion devices described herein. For example, the methods and devices described herein for placing an implant into a joint or between two bone portions can be used with fixation devices that utilized flexible fasteners of different configuration and/or fasteners that are not flexible (e.g., rods, screws, and/or clamps) that extend across the joint or between bone portions.
In addition, methods and devices described herein for placing an implant into a joint or between two bone portions can also be used in non-fusion applications. For example, U.S. Pat. No. 7,846,183 and/or U.S. Pat. No. 8,740,949 (which are incorporated by reference herein) disclose various devices and methods for the augmentation and restoration of vertebral facet joints. Several embodiments involve the insertion of implant (e.g., a disk) into the facet joint. Several embodiments include a hole or slot in the implant and/or a flexible member that can extend across an opening formed in the facet joint and the implant. In such embodiments, the techniques and devices described herein for advancing a flexible member through the facet joint and then using the flexible member to urge the implant into the facet joint can be used.
It should also be appreciated that the methods and devices herein are not limited to the facet joint but can also be used to insert an implant between to bone portions and/or other joints in the body.
Although this invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while several variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. It should be understood that various features and aspects of the disclosed embodiments can be combined with, or substituted for, one another in order to form varying modes of the disclosed invention. For all the embodiments described above, the steps of the methods need not be performed sequentially. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
This application is a divisional of U.S. patent application Ser. No. 14/491,820, filed on Sep. 19, 2014, which claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application No. 61/883,911, filed Sep. 27, 2013, the disclosures of each are incorporated by reference herein in their entirety. This application incorporates by reference U.S. Pat. No. 8,740,949 (U.S. application Ser. No. 13/033,791, filed Feb. 24, 2011); U.S. Patent Publication 2012/0221049 (U.S. application Ser. No. 13/403,698, filed Feb. 23, 2012), U.S. Pat. No. 7,846,183 (application Ser. No. 10/865,073, filed Jun. 10, 2004), U.S. Pat. No. 8,652,137 (U.S. application Ser. No. 12/035,366, filed Feb. 21, 2008), U.S. Publication 2011/0040301 (application Ser. No. 12/859,009, filed Aug. 18, 2010), in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
86016 | Howell | Jan 1869 | A |
1630239 | Binkley et al. | May 1927 | A |
1822280 | Ervay | Sep 1931 | A |
1822330 | Anslie | Sep 1931 | A |
2486303 | Longfellow | Oct 1949 | A |
2706023 | Merritt | Apr 1955 | A |
2967282 | Schwartz et al. | Jan 1961 | A |
3111945 | Von Solbrig | Nov 1963 | A |
3149808 | Weckesser | Sep 1964 | A |
3570497 | Lemole | Mar 1971 | A |
3867728 | Stubstad et al. | Feb 1975 | A |
3875595 | Froning | Apr 1975 | A |
3879767 | Stubstad | Apr 1975 | A |
4001896 | Arkangel | Jan 1977 | A |
4037603 | Wendorff | Jul 1977 | A |
4085466 | Goodfellow et al. | Apr 1978 | A |
4119091 | Partridge | Oct 1978 | A |
4156296 | Johnson et al. | May 1979 | A |
4231121 | Lewis | Nov 1980 | A |
D261935 | Halloran | Nov 1981 | S |
4312337 | Donohue | Jan 1982 | A |
4323217 | Dochterman | Apr 1982 | A |
4349921 | Kuntz | Sep 1982 | A |
4502161 | Wall | Mar 1985 | A |
D279502 | Halloran | Jul 1985 | S |
D279503 | Halloran | Jul 1985 | S |
4535764 | Ebert | Aug 1985 | A |
4573458 | Lower | Mar 1986 | A |
4573459 | Lower | Mar 1986 | A |
4634445 | Helal | Jan 1987 | A |
4662371 | Whipple et al. | May 1987 | A |
4706659 | Matthews et al. | Nov 1987 | A |
4714469 | Kenna | Dec 1987 | A |
4722331 | Fox | Feb 1988 | A |
4730615 | Sutherland et al. | Mar 1988 | A |
4759766 | Buettner-Janz et al. | Jul 1988 | A |
4759769 | Hedman et al. | Jul 1988 | A |
4772287 | Ray et al. | Sep 1988 | A |
4773402 | Asher et al. | Sep 1988 | A |
4834757 | Brantigan | May 1989 | A |
4863477 | Monson | Sep 1989 | A |
4904260 | Ray et al. | Feb 1990 | A |
4907577 | Wu | Mar 1990 | A |
4911718 | Lee et al. | Mar 1990 | A |
4919667 | Richmond | Apr 1990 | A |
4923471 | Morgan | May 1990 | A |
4936848 | Bagby | Jun 1990 | A |
4941466 | Romano | Jul 1990 | A |
4959065 | Arnett et al. | Sep 1990 | A |
4969909 | Barouk | Nov 1990 | A |
5000165 | Watanabe | Mar 1991 | A |
5002546 | Romano | Mar 1991 | A |
5011484 | Bréard | Apr 1991 | A |
5015255 | Kuslich | May 1991 | A |
5047055 | Bao et al. | Sep 1991 | A |
5062845 | Kuslich | Nov 1991 | A |
5071437 | Steffee | Dec 1991 | A |
5092866 | Breard et al. | Mar 1992 | A |
5112013 | Tolbert et al. | May 1992 | A |
5112346 | Hiltebrandt et al. | May 1992 | A |
5127912 | Ray et al. | Jul 1992 | A |
5135188 | Anderson et al. | Aug 1992 | A |
5147404 | Downey | Sep 1992 | A |
5171280 | Baumgartner | Dec 1992 | A |
5192326 | Bao et al. | Mar 1993 | A |
5192327 | Brantigan | Mar 1993 | A |
5209755 | Abrahan et al. | May 1993 | A |
5258031 | Salib et al. | Nov 1993 | A |
5282861 | Kaplan | Feb 1994 | A |
5286249 | Thibodaux | Feb 1994 | A |
5300073 | Ray et al. | Apr 1994 | A |
5306275 | Bryan | Apr 1994 | A |
5306308 | Gross et al. | Apr 1994 | A |
5306309 | Wagner et al. | Apr 1994 | A |
5330479 | Whitmore | Jul 1994 | A |
5360431 | Puno et al. | Nov 1994 | A |
5368596 | Brookhart | Nov 1994 | A |
5370697 | Baumgartner | Dec 1994 | A |
5372598 | Luhr et al. | Dec 1994 | A |
5400784 | Durand et al. | Mar 1995 | A |
5401269 | Buttner-Janz et al. | Mar 1995 | A |
5413576 | Rivard | May 1995 | A |
5415661 | Holmes | May 1995 | A |
5425773 | Boyd et al. | Jun 1995 | A |
5437672 | Alleyne | Aug 1995 | A |
5445639 | Kuslich et al. | Aug 1995 | A |
5458642 | Beer et al. | Oct 1995 | A |
5458643 | Oka et al. | Oct 1995 | A |
5462542 | Alesi, Jr. | Oct 1995 | A |
5487756 | Kallesoe et al. | Jan 1996 | A |
5491882 | Walston et al. | Feb 1996 | A |
5496318 | Howland et al. | Mar 1996 | A |
5507823 | Walston et al. | Apr 1996 | A |
5509918 | Romano | Apr 1996 | A |
5514180 | Heggeness et al. | May 1996 | A |
5527312 | Ray | Jun 1996 | A |
5527314 | Brumfield et al. | Jun 1996 | A |
5534028 | Bao et al. | Jul 1996 | A |
5534030 | Navarro et al. | Jul 1996 | A |
5540706 | Aust et al. | Jul 1996 | A |
5545229 | Parsons et al. | Aug 1996 | A |
5549619 | Peters et al. | Aug 1996 | A |
5556431 | Buttner-Janz | Sep 1996 | A |
5562738 | Boyd et al. | Oct 1996 | A |
5571105 | Gundolf | Nov 1996 | A |
5571131 | Ek et al. | Nov 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5571191 | Fitz | Nov 1996 | A |
5577995 | Walker et al. | Nov 1996 | A |
5586989 | Bray, Jr. | Dec 1996 | A |
5591165 | Jackson | Jan 1997 | A |
5603713 | Aust et al. | Feb 1997 | A |
5638700 | Shechter | Jun 1997 | A |
5645597 | Krapiva | Jul 1997 | A |
5645599 | Samani | Jul 1997 | A |
5649947 | Auerbach et al. | Jul 1997 | A |
5653762 | Pisharodi | Aug 1997 | A |
5674295 | Ray et al. | Oct 1997 | A |
5674296 | Bryan et al. | Oct 1997 | A |
5676701 | Yuan et al. | Oct 1997 | A |
5683464 | Wagner et al. | Nov 1997 | A |
5683466 | Vitale | Nov 1997 | A |
5700265 | Romano | Dec 1997 | A |
5702450 | Bisserie | Dec 1997 | A |
5707373 | Sevrain et al. | Jan 1998 | A |
5713542 | Benoit | Feb 1998 | A |
5716415 | Steffee | Feb 1998 | A |
5725582 | Bevan et al. | Mar 1998 | A |
5741260 | Songer et al. | Apr 1998 | A |
5741261 | Moskovitz et al. | Apr 1998 | A |
D395138 | Ohata | Jun 1998 | S |
5766251 | Koshino | Jun 1998 | A |
5766253 | Brosnahan | Jun 1998 | A |
5772663 | Whiteside et al. | Jun 1998 | A |
5797916 | McDowell | Aug 1998 | A |
5824093 | Ray et al. | Oct 1998 | A |
5824094 | Serhan et al. | Oct 1998 | A |
5836948 | Zucherman et al. | Nov 1998 | A |
5851208 | Trott | Dec 1998 | A |
5860977 | Zucherman et al. | Jan 1999 | A |
5865846 | Bryan et al. | Feb 1999 | A |
5868745 | Alleyne | Feb 1999 | A |
5876404 | Zucherman et al. | Mar 1999 | A |
5879396 | Walston et al. | Mar 1999 | A |
5888203 | Goldberg | Mar 1999 | A |
5893889 | Harrington | Apr 1999 | A |
5895428 | Berry | Apr 1999 | A |
RE36221 | Breard et al. | Jun 1999 | E |
5918604 | Whelan | Jul 1999 | A |
5951555 | Rehak et al. | Sep 1999 | A |
5964765 | Fenton et al. | Oct 1999 | A |
5993452 | Vandewalle | Nov 1999 | A |
5997542 | Burke | Dec 1999 | A |
6001130 | Bryan et al. | Dec 1999 | A |
6014588 | Fitz | Jan 2000 | A |
6019763 | Nakamura et al. | Feb 2000 | A |
6019792 | Cauthen | Feb 2000 | A |
6039763 | Shelokov | Mar 2000 | A |
6048342 | Zucherman et al. | Apr 2000 | A |
6050998 | Fletcher | Apr 2000 | A |
6063121 | Xavier et al. | May 2000 | A |
6066325 | Wallace et al. | May 2000 | A |
6068630 | Zucherman et al. | May 2000 | A |
RE36758 | Fitz | Jun 2000 | E |
6080157 | Cathro et al. | Jun 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6102347 | Benoit | Aug 2000 | A |
6106558 | Picha | Aug 2000 | A |
6113637 | Gi, II et al. | Sep 2000 | A |
6132464 | Martin | Oct 2000 | A |
6132465 | Ray et al. | Oct 2000 | A |
6146422 | Lawson | Nov 2000 | A |
6156067 | Bryan et al. | Dec 2000 | A |
6179839 | Weiss et al. | Jan 2001 | B1 |
D439340 | Michelson | Mar 2001 | S |
6200322 | Branch et al. | Mar 2001 | B1 |
6293949 | Justis et al. | Sep 2001 | B1 |
D450122 | Michelson | Nov 2001 | S |
6325803 | Schumacher et al. | Dec 2001 | B1 |
D454953 | Michelson | Mar 2002 | S |
6368325 | McKinley et al. | Apr 2002 | B1 |
6368350 | Erickson et al. | Apr 2002 | B1 |
6371958 | Overaker | Apr 2002 | B1 |
6375573 | Romano | Apr 2002 | B2 |
6379386 | Resch et al. | Apr 2002 | B1 |
D460188 | Michelson | Jul 2002 | S |
D460189 | Michelson | Jul 2002 | S |
6419678 | Asfora | Jul 2002 | B1 |
6419703 | Fallin et al. | Jul 2002 | B1 |
6436099 | Drewry et al. | Aug 2002 | B1 |
6436101 | Hamada et al. | Aug 2002 | B1 |
6436146 | Hassler et al. | Aug 2002 | B1 |
D463560 | Michelson | Sep 2002 | S |
6447544 | Michelson | Sep 2002 | B1 |
6470207 | Simon et al. | Oct 2002 | B1 |
6565605 | Goble et al. | May 2003 | B2 |
6572617 | Senegas | Jun 2003 | B1 |
6579318 | Varga et al. | Jun 2003 | B2 |
6579319 | Goble et al. | Jun 2003 | B2 |
6589244 | Sevrain et al. | Jul 2003 | B1 |
6600956 | Maschino et al. | Jul 2003 | B2 |
6607530 | Carl et al. | Aug 2003 | B1 |
6610091 | Reiley | Aug 2003 | B1 |
D479331 | Pike et al. | Sep 2003 | S |
6626944 | Taylor | Sep 2003 | B1 |
6641614 | Wagner et al. | Nov 2003 | B1 |
6656195 | Peters et al. | Dec 2003 | B2 |
6669697 | Pisharodi | Dec 2003 | B1 |
6669729 | Chin | Dec 2003 | B2 |
6706068 | Ferree | Mar 2004 | B2 |
6743232 | Overaker et al. | Jun 2004 | B2 |
6761720 | Senegas | Jul 2004 | B1 |
6764491 | Frey et al. | Jul 2004 | B2 |
6770095 | Grinberg et al. | Aug 2004 | B2 |
6783527 | Drewry et al. | Aug 2004 | B2 |
6790210 | Cragg et al. | Sep 2004 | B1 |
6802863 | Lawson et al. | Oct 2004 | B2 |
6811567 | Reiley | Nov 2004 | B2 |
6902566 | Zucherman et al. | Jun 2005 | B2 |
6908484 | Zubok et al. | Jun 2005 | B2 |
6966930 | Arnin et al. | Nov 2005 | B2 |
6974478 | Reiley et al. | Dec 2005 | B2 |
6974479 | Trieu | Dec 2005 | B2 |
D517404 | Schluter | Mar 2006 | S |
7008429 | Golobek | Mar 2006 | B2 |
7013675 | Marquez-Pickering | Mar 2006 | B2 |
7051451 | Augostino et al. | May 2006 | B2 |
7074238 | Stinson et al. | Jul 2006 | B2 |
7101375 | Zucherman et al. | Sep 2006 | B2 |
7223269 | Chappuis | May 2007 | B2 |
D565180 | Liao | Mar 2008 | S |
7371238 | Sololeski et al. | May 2008 | B2 |
7458981 | Fielding et al. | Dec 2008 | B2 |
7517358 | Petersen | Apr 2009 | B2 |
7537611 | Lee | May 2009 | B2 |
7559940 | McGuire et al. | Jul 2009 | B2 |
7563286 | Gerber et al. | Jul 2009 | B2 |
7585300 | Cha | Sep 2009 | B2 |
7608104 | Yuan et al. | Oct 2009 | B2 |
7695472 | Young | Apr 2010 | B2 |
7799077 | Lang et al. | Sep 2010 | B2 |
7806895 | Weier et al. | Oct 2010 | B2 |
7846183 | Blain | Dec 2010 | B2 |
7862590 | Lim et al. | Jan 2011 | B2 |
7935136 | Alamin et al. | May 2011 | B2 |
D643121 | Milford et al. | Aug 2011 | S |
7993370 | Jahng | Aug 2011 | B2 |
7998172 | Blain | Aug 2011 | B2 |
8052728 | Hestad | Nov 2011 | B2 |
8109971 | Hale | Feb 2012 | B2 |
8133225 | Pieske | Mar 2012 | B2 |
8163016 | Linares | Apr 2012 | B2 |
8192468 | Biedermann et al. | Jun 2012 | B2 |
8216275 | Fielding et al. | Jul 2012 | B2 |
8246655 | Jackson et al. | Aug 2012 | B2 |
8292954 | Robinson et al. | Oct 2012 | B2 |
8306307 | Koike et al. | Nov 2012 | B2 |
8394125 | Assell | Mar 2013 | B2 |
8460346 | Ralph et al. | Jun 2013 | B2 |
8486078 | Carl et al. | Jul 2013 | B2 |
8496691 | Blain | Jul 2013 | B2 |
8579903 | Carl | Nov 2013 | B2 |
8652137 | Blain et al. | Feb 2014 | B2 |
8740942 | Blain | Jun 2014 | B2 |
8740949 | Blain | Jun 2014 | B2 |
8753345 | McCormack et al. | Jun 2014 | B2 |
8784423 | Kowarsch et al. | Jul 2014 | B2 |
8858597 | Blain | Oct 2014 | B2 |
8882804 | Blain | Nov 2014 | B2 |
8961613 | Assell et al. | Feb 2015 | B2 |
D724733 | Blain et al. | Mar 2015 | S |
8974456 | Allen et al. | Mar 2015 | B2 |
8979529 | Marcus | Mar 2015 | B2 |
8992533 | Blain et al. | Mar 2015 | B2 |
8998953 | Blain | Apr 2015 | B2 |
9017389 | Assell et al. | Apr 2015 | B2 |
9060787 | Blain et al. | Jun 2015 | B2 |
9101410 | Urrea | Aug 2015 | B1 |
D739935 | Blain et al. | Sep 2015 | S |
9149283 | Assell et al. | Oct 2015 | B2 |
9161763 | Assell et al. | Oct 2015 | B2 |
9179943 | Blain | Nov 2015 | B2 |
9220547 | Blain et al. | Dec 2015 | B2 |
D748262 | Blain | Jan 2016 | S |
9233006 | Assell et al. | Jan 2016 | B2 |
D748793 | Blain | Feb 2016 | S |
9265546 | Blain | Feb 2016 | B2 |
9271765 | Blain | Mar 2016 | B2 |
9301786 | Blain | Apr 2016 | B2 |
9314277 | Assell et al. | Apr 2016 | B2 |
9345488 | Assell et al. | May 2016 | B2 |
9421044 | Blain et al. | Aug 2016 | B2 |
D765853 | Blain et al. | Sep 2016 | S |
D765854 | Blain et al. | Sep 2016 | S |
9456855 | Blain et al. | Oct 2016 | B2 |
9517077 | Blain et al. | Dec 2016 | B2 |
D777921 | Blain et al. | Jan 2017 | S |
D780315 | Blain et al. | Feb 2017 | S |
9572602 | Blain et al. | Feb 2017 | B2 |
D790062 | Blain et al. | Jun 2017 | S |
9675387 | Blain | Jun 2017 | B2 |
9743937 | Blain et al. | Aug 2017 | B2 |
9808294 | Blain | Nov 2017 | B2 |
9820784 | Blain et al. | Nov 2017 | B2 |
9839450 | Blain et al. | Dec 2017 | B2 |
D810942 | Blain et al. | Feb 2018 | S |
D812754 | Blain et al. | Mar 2018 | S |
9936984 | Blain | Apr 2018 | B2 |
20010018614 | Bianchi | Aug 2001 | A1 |
20020018799 | Spector et al. | Feb 2002 | A1 |
20020019637 | Frey et al. | Feb 2002 | A1 |
20020029039 | Zucherman et al. | Mar 2002 | A1 |
20020040227 | Harari | Apr 2002 | A1 |
20020065557 | Goble et al. | May 2002 | A1 |
20020072800 | Goble et al. | Jun 2002 | A1 |
20020077700 | Varga et al. | Jun 2002 | A1 |
20020086047 | Mueller et al. | Jul 2002 | A1 |
20020120335 | Angelucci et al. | Aug 2002 | A1 |
20020123806 | Reiley | Sep 2002 | A1 |
20020151895 | Soboleski et al. | Oct 2002 | A1 |
20020173800 | Dreyfuss et al. | Nov 2002 | A1 |
20020173813 | Peterson et al. | Nov 2002 | A1 |
20020198527 | Muckter | Dec 2002 | A1 |
20030004572 | Goble et al. | Jan 2003 | A1 |
20030028250 | Reiley et al. | Feb 2003 | A1 |
20030040797 | Fallin et al. | Feb 2003 | A1 |
20030120343 | Whelan | Jun 2003 | A1 |
20030176919 | Schmieding | Sep 2003 | A1 |
20030176922 | Lawson et al. | Sep 2003 | A1 |
20030187454 | Gill et al. | Oct 2003 | A1 |
20030191532 | Goble et al. | Oct 2003 | A1 |
20030204259 | Goble et al. | Oct 2003 | A1 |
20030216669 | Lang et al. | Nov 2003 | A1 |
20030233146 | Grinberg et al. | Dec 2003 | A1 |
20040006391 | Reiley | Jan 2004 | A1 |
20040010318 | Ferree | Jan 2004 | A1 |
20040024462 | Ferree et al. | Feb 2004 | A1 |
20040049271 | Biedermann et al. | Mar 2004 | A1 |
20040049272 | Reiley | Mar 2004 | A1 |
20040049273 | Reiley | Mar 2004 | A1 |
20040049274 | Reiley | Mar 2004 | A1 |
20040049275 | Reiley | Mar 2004 | A1 |
20040049276 | Reiley | Mar 2004 | A1 |
20040049277 | Reiley | Mar 2004 | A1 |
20040049278 | Reiley | Mar 2004 | A1 |
20040049281 | Reiley | Mar 2004 | A1 |
20040059429 | Amin et al. | Mar 2004 | A1 |
20040087954 | Allen et al. | May 2004 | A1 |
20040116927 | Graf | Jun 2004 | A1 |
20040127989 | Dooris et al. | Jul 2004 | A1 |
20040143264 | McAfee | Jul 2004 | A1 |
20040176844 | Zubok et al. | Sep 2004 | A1 |
20040199166 | Schmieding et al. | Oct 2004 | A1 |
20040215341 | Sybert et al. | Oct 2004 | A1 |
20040230201 | Yuan et al. | Nov 2004 | A1 |
20040230304 | Yuan et al. | Nov 2004 | A1 |
20050010291 | Stinson et al. | Jan 2005 | A1 |
20050015146 | Louis et al. | Jan 2005 | A1 |
20050043797 | Lee | Feb 2005 | A1 |
20050043799 | Reiley | Feb 2005 | A1 |
20050049705 | Hale et al. | Mar 2005 | A1 |
20050055096 | Serh an et al. | Mar 2005 | A1 |
20050059972 | Biscup | Mar 2005 | A1 |
20050131409 | Chervitz et al. | Jun 2005 | A1 |
20050131538 | Chervitz et al. | Jun 2005 | A1 |
20050143818 | Yuan et al. | Jun 2005 | A1 |
20050159746 | Grab et al. | Jul 2005 | A1 |
20050197700 | Boehem et al. | Sep 2005 | A1 |
20050216017 | Fielding et al. | Sep 2005 | A1 |
20050240201 | Yeung | Oct 2005 | A1 |
20050251256 | Reiley | Nov 2005 | A1 |
20050256494 | Datta | Nov 2005 | A1 |
20060004367 | Alamin et al. | Jan 2006 | A1 |
20060036323 | Carl et al. | Feb 2006 | A1 |
20060041311 | McLeer | Feb 2006 | A1 |
20060084985 | Kim | Apr 2006 | A1 |
20060085006 | Ek et al. | Apr 2006 | A1 |
20060085072 | Funk et al. | Apr 2006 | A1 |
20060111782 | Petersen | May 2006 | A1 |
20060116684 | Whelan | Jun 2006 | A1 |
20060149375 | Yuan et al. | Jul 2006 | A1 |
20060200137 | Soboleski et al. | Sep 2006 | A1 |
20060235412 | Blain | Oct 2006 | A1 |
20060241601 | Trautwein et al. | Oct 2006 | A1 |
20060241758 | Peterman et al. | Oct 2006 | A1 |
20060293691 | Mitra et al. | Dec 2006 | A1 |
20070055236 | Hudgins et al. | Mar 2007 | A1 |
20070055252 | Blain et al. | Mar 2007 | A1 |
20070078464 | Jones et al. | Apr 2007 | A1 |
20070100452 | Prosser | May 2007 | A1 |
20070118218 | Hooper | May 2007 | A1 |
20070123863 | Winslow et al. | May 2007 | A1 |
20070149976 | Hale et al. | Jun 2007 | A1 |
20070179619 | Grab | Aug 2007 | A1 |
20070250166 | McKay | Oct 2007 | A1 |
20070270812 | Peckham | Nov 2007 | A1 |
20080009866 | Alamin et al. | Jan 2008 | A1 |
20080058929 | Whelan | Mar 2008 | A1 |
20080177264 | Alamin et al. | Jul 2008 | A1 |
20080183211 | Lamborne et al. | Jul 2008 | A1 |
20080228225 | Trautwein et al. | Sep 2008 | A1 |
20080287996 | Soholeski et al. | Nov 2008 | A1 |
20090005818 | Chin et al. | Jan 2009 | A1 |
20090005873 | Slivka et al. | Jan 2009 | A1 |
20090018662 | Pasquet et al. | Jan 2009 | A1 |
20090024166 | Carl et al. | Jan 2009 | A1 |
20090076617 | Ralph et al. | Mar 2009 | A1 |
20090125066 | Kraus et al. | May 2009 | A1 |
20090138048 | Baccelli et al. | May 2009 | A1 |
20090171360 | Whelan | Jul 2009 | A1 |
20090198282 | Fielding et al. | Aug 2009 | A1 |
20090264928 | Blain | Oct 2009 | A1 |
20090264929 | Alamin et al. | Oct 2009 | A1 |
20090270918 | Attia et al. | Oct 2009 | A1 |
20090270929 | Suddaby | Oct 2009 | A1 |
20090306716 | Beger et al. | Dec 2009 | A1 |
20090326589 | Lemoine et al. | Dec 2009 | A1 |
20100010548 | Hermida Ochoa | Jan 2010 | A1 |
20100076503 | Beyar et al. | Mar 2010 | A1 |
20100131008 | Overes et al. | May 2010 | A1 |
20100179553 | Ralph et al. | Jul 2010 | A1 |
20100185241 | Malandain et al. | Jul 2010 | A1 |
20100191286 | Butler | Jul 2010 | A1 |
20100204700 | Falahee | Aug 2010 | A1 |
20100204732 | Alamin et al. | Aug 2010 | A1 |
20100234894 | Alamin et al. | Sep 2010 | A1 |
20100274289 | Carls et al. | Oct 2010 | A1 |
20100298829 | Schaller et al. | Nov 2010 | A1 |
20100318133 | Tornier | Dec 2010 | A1 |
20110022089 | Assell et al. | Jan 2011 | A1 |
20110040301 | Blain et al. | Feb 2011 | A1 |
20110098816 | Jacob et al. | Apr 2011 | A1 |
20110160772 | Arcenio et al. | Jun 2011 | A1 |
20110172712 | Chee et al. | Jul 2011 | A1 |
20110245875 | Karim | Oct 2011 | A1 |
20110295318 | Alamin et al. | Dec 2011 | A1 |
20110313456 | Blain | Dec 2011 | A1 |
20120035658 | Goble et al. | Feb 2012 | A1 |
20120046749 | Tatsumi | Feb 2012 | A1 |
20120101502 | Kartalian et al. | Apr 2012 | A1 |
20120150231 | Alamin et al. | Jun 2012 | A1 |
20120221048 | Blain | Aug 2012 | A1 |
20120221049 | Blain | Aug 2012 | A1 |
20120245586 | Lehenkari et al. | Sep 2012 | A1 |
20120271354 | Baccelli et al. | Oct 2012 | A1 |
20120277801 | Marik et al. | Nov 2012 | A1 |
20120310244 | Blain et al. | Dec 2012 | A1 |
20130023878 | Belliard et al. | Jan 2013 | A1 |
20130041410 | Hestad et al. | Feb 2013 | A1 |
20130079778 | Azuero et al. | Mar 2013 | A1 |
20130123923 | Pavlov et al. | May 2013 | A1 |
20130253649 | Davis | Sep 2013 | A1 |
20130325065 | Malandain et al. | Dec 2013 | A1 |
20140012318 | Goel | Jan 2014 | A1 |
20140066758 | Marik et al. | Mar 2014 | A1 |
20140228883 | Blain | Aug 2014 | A1 |
20140257397 | Akbarnia et al. | Sep 2014 | A1 |
20140277142 | Blain | Sep 2014 | A1 |
20140277148 | Blain et al. | Sep 2014 | A1 |
20140277149 | Rooney et al. | Sep 2014 | A1 |
20140336653 | Bromer | Nov 2014 | A1 |
20140378976 | Garcia | Dec 2014 | A1 |
20150081023 | Blain | Mar 2015 | A1 |
20150094766 | Blain et al. | Apr 2015 | A1 |
20150094767 | Blain et al. | Apr 2015 | A1 |
20150119988 | Assell et al. | Apr 2015 | A1 |
20150164516 | Blain et al. | Jun 2015 | A1 |
20150164652 | Assell et al. | Jun 2015 | A1 |
20150190149 | Assell et al. | Jul 2015 | A1 |
20150196330 | Blain | Jul 2015 | A1 |
20150209096 | Gephart | Jul 2015 | A1 |
20150257770 | Assell et al. | Sep 2015 | A1 |
20150257773 | Blain | Sep 2015 | A1 |
20150327872 | Assell et al. | Nov 2015 | A1 |
20160051294 | Blain | Feb 2016 | A1 |
20160113692 | Knoepfle | Apr 2016 | A1 |
20160128739 | Blain et al. | May 2016 | A1 |
20160128838 | Assell et al. | May 2016 | A1 |
20160213481 | Blain | Jul 2016 | A1 |
20160324549 | Blain | Nov 2016 | A1 |
20170105767 | Blain | Apr 2017 | A1 |
20170239060 | Blain | Aug 2017 | A1 |
20170281232 | Smith | Oct 2017 | A1 |
20180049780 | Blain | Feb 2018 | A1 |
20180085148 | Blain | Mar 2018 | A1 |
20180085149 | Blain | Mar 2018 | A1 |
Number | Date | Country |
---|---|---|
2 437 575 | Apr 2009 | CA |
93 04 368 | May 1993 | DE |
201 12 123 | Sep 2001 | DE |
101 35 771 | Feb 2003 | DE |
0 238 219 | Sep 1987 | EP |
0 322 334 | Jun 1989 | EP |
0 392 124 | Oct 1990 | EP |
0 610 837 | Aug 1994 | EP |
0 928 603 | Jul 1999 | EP |
1 201 202 | May 2002 | EP |
1 201 256 | May 2002 | EP |
2 138 122 | Dec 2009 | EP |
2 919 717 | Sep 2015 | EP |
2 704 745 | Nov 1994 | FR |
2 722 980 | Feb 1996 | FR |
2 366 736 | Mar 2002 | GB |
53-005889 | Jan 1978 | JP |
62-270147 | Nov 1987 | JP |
03-100154 | Apr 1991 | JP |
03-240660 | Oct 1991 | JP |
08-509918 | Oct 1996 | JP |
10-179622 | Jul 1998 | JP |
2000-210297 | Aug 2000 | JP |
2003-079649 | Mar 2003 | JP |
2004-508888 | Mar 2004 | JP |
2004-181236 | Jul 2004 | JP |
2006-230722 | Sep 2006 | JP |
2006-528540 | Dec 2006 | JP |
2007-503884 | Mar 2007 | JP |
2007-517627 | Jul 2007 | JP |
2007-190389 | Aug 2007 | JP |
2007-521881 | Aug 2007 | JP |
2008-510526 | Apr 2008 | JP |
2009-533167 | Sep 2009 | JP |
2010-173739 | Aug 2010 | JP |
2012-521221 | Sep 2012 | JP |
2013-534451 | Sep 2013 | JP |
2014-513583 | Jun 2014 | JP |
6012309 | Jan 2007 | MX |
WO 93014721 | Aug 1993 | WO |
WO 94004088 | Mar 1994 | WO |
WO 97047246 | Dec 1997 | WO |
WO 98048717 | Nov 1998 | WO |
WO 99023963 | May 1999 | WO |
WO 00038582 | Jul 2000 | WO |
WO 00053126 | Sep 2000 | WO |
WO 01030248 | May 2001 | WO |
WO 02045765 | Jun 2002 | WO |
WO 02065954 | Aug 2002 | WO |
WO 02096300 | Dec 2002 | WO |
WO 03101350 | Dec 2003 | WO |
WO 2004071358 | Aug 2004 | WO |
WO 2005020850 | Mar 2005 | WO |
WO 2005072661 | Aug 2005 | WO |
WO 2006023980 | Mar 2006 | WO |
WO 2006096803 | Sep 2006 | WO |
WO 2008008522 | Jan 2008 | WO |
WO 2009021876 | Feb 2009 | WO |
WO 2010060072 | May 2010 | WO |
WO 2010122472 | Oct 2010 | WO |
WO 2011011621 | Jan 2011 | WO |
WO 2012007941 | Jan 2012 | WO |
WO 2012116266 | Aug 2012 | WO |
WO 2013022880 | Feb 2013 | WO |
WO 2013138655 | Sep 2013 | WO |
WO 2014078541 | May 2014 | WO |
WO 2016044432 | Mar 2016 | WO |
Entry |
---|
3rd Party Lab Notebook, “Facet Cartilage Repair,” dated May 20, 2003 in 2 pages. |
ArthroTek, “CurvTek® Bone Tunneling System,” Surgical Technique, 2000, pp. 6. |
Ash, H.E., “Proximal Interphalangeal Joint Dimensions for the Design of a Surface Replacement Prosthesis”, School of Engineering, University of Durham, Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine Feb. 1996, vol. 210, No. 2, pp. 95-108. |
E-mail from 3rd Party citing U.S. Appl. Nos. 60/721,909; 60/750,005 and 60/749,000, initial e-mail dated May 11, 2009, reply e-mail dated May 18, 2009. |
King et al., “Mechanism of Spinal Injury Due to Caudocephalad Acceleration,” Symposium on the Lumbar Spine, Orthopedic Clinic of North America, Jan. 1975, vol. 6, pp. 19-31. |
Parteq Innovations, “Facet Joint Implants & Resurfacing Devices,” Technology Opportunity Bulletin, Tech ID 1999-012, Queen's University, Ontario Canada. |
Official Communication in Australian Application No. 2005213459, dated Dec. 11, 2009. |
Official Communication in Australian Application No. 2005213459, dated Dec. 15, 2010. |
Official Communication in Australian Application No. 2011226832, dated Sep. 4, 2012. |
Official Communication in Australian Application No. 2011226832, dated Oct. 31, 2012. |
Official Communication in Australian Application No. AU2013237744, dated Sep. 2, 2014. |
Notice of Acceptance in Australian Application No. AU2013237744, dated Apr. 23, 2015. |
Official Communication in Australian Application No. AU2015205875, dated Apr. 2, 2016. |
Official Communication in Canadian Application No. 2,555,355, dated Sep. 2, 2011. |
Official Communication in Canadian Application No. 2,803,783, dated Sep. 29, 2014. |
Official Communication in Canadian Application No. 2,803,783, dated Aug. 5, 2015. |
Official Communication in European Application No. 05712981.9, dated Jul. 24, 2007. |
Official Communication in European Application No. 05712981.9, dated Mar. 10, 2008. |
Official Communication in European Application No. 05712981.9, dated Apr. 6, 2009. |
Official Communication in European Application No. 05712981.9, dated Jun. 15, 2010. |
Official Communication in European Application No. 10178979.0, dated Mar. 14, 2011. |
Official Communication in European Application No. 10178979.0, dated Nov. 13, 2012. |
Official Communication in European Application No. 10178979.0, dated Aug. 5, 2013. |
Official Communication in European Application No. 14175088.5, dated Sep. 8, 2014. |
Official Communication in European Application No. 14175088.5, dated Nov. 18, 2015. |
Official Communication in Japanese Application No. 2006-552309, dated May 25, 2010. |
Official Communication in Japanese Application No. 2006-552309, dated Feb. 15, 2011. |
Official Communication in Japanese Application No. 2010-221380, dated Feb. 15, 2011. |
Official Communication in Japanese Application No. 2012-272106, dated Dec. 3, 2013. |
Official Communication in Japanese Application No. 2012-272106, dated May 26, 2014. |
Official Communication in Japanese Application No. 2012-272106, dated Feb. 23, 2015. |
Official Communication in Japanese Application No. 2012-272106, dated Nov. 2, 2015. |
International Search Report and Written Opinion in International Application No. PCT/US2005/003753, dated Dec. 5, 2006. |
International Preliminary Report and Written Opinion in International App No. PCT/US2005/003753, dated Jan. 9, 2007. |
Official Communication in European Application No. 08730413.5, dated Feb. 16, 2012. |
Official Communication in European Application No. 14177951.2, dated Nov. 13, 2014. |
International Search Report and Written Opinion in International Application No. PCT/US2008/054607, dated Jul. 10, 2008. |
International Preliminary Report on Patentability in International Application No. PCT/US2008/054607, dated Sep. 3, 2009. |
Official Communication in Australian Application No. 2011292297, dated Jul. 10, 2013. |
Official Communication in European Application No. 11818586.7, dated Nov. 6, 2014. |
Official Communication in Japanese Application No. 2013-524882, dated Mar. 2, 2015. |
International Search Report and Written Opinion in International Application No. PCT/US2011/047432, dated Dec. 12, 2011. |
International Preliminary Report on Patentability in International Application No. PCT/US2011/047432, dated Feb. 28, 2013. |
Official Communication in Australian Application No. AU2012222229, dated Aug. 21, 2015. |
Official Communication in Australian Application No. AU2012222230, dated Aug. 21, 2015. |
Official Communication in Japanese Application No. JP 2013-555591, dated Jan. 4, 2016. |
Official Communication in Japanese Application No. JP 2013-555592, dated Dec. 7, 2015. |
International Search Report in International Application No. PCT/US2012/026470, dated May 30, 2012. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2012/026470, dated Sep. 6, 2013. |
International Search Report and Written Opinion in International Application No. PCT/US2012/026472, dated Jun. 20, 2012. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2012/026472, dated Mar. 12, 2014. |
International Search Report and Written Opinion in International Application No. PCT/US2014/019302, dated May 18, 2015. |
International Search Report and Written Opinion in International Application No. PCT/US2014/019325, dated Jun. 17, 2014. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2014/019325, dated Sep. 24, 2015. |
International Search Report and Written Opinion in International Application No. PCT/US2014/056598, dated Dec. 29, 2014. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2014/056598, dated Apr. 7, 2016. |
International Search Report and Written Opinion in International Application No. PCT/US2015/050441, dated Dec. 28, 2015. |
International Search Report and Written Opinion in International Application No. PCT/US2016/013062, dated Mar. 16, 2016. |
International Search Report in International Application No. PCT/CA2002/000193 filed Feb. 15, 2002, dated Jun. 18, 2002. |
International Search Report and Written Opinion in International Application No. PCT/US2004/028094, dated May 16, 2005. |
International Preliminary Report on Patentability in International Application No. PCT/US2004/028094, dated Feb. 25, 2013. |
International Search Report in International Application No. PCT/US2005/000987 filed Jan. 13, 2005, dated May 24, 2005. |
International Preliminary Report on Patentability in International Application No. PCT/US2005/000987 filed Jan. 13, 2005, dated Jan. 17, 2006. |
ArthroTek, “CurvTek® Bone Tunneling System,” User's Manual, 2000, pp. 20. |
Official Communication in Australian Application No. AU2015205875, dated Jun. 15, 2016. |
Official Communication in Canadian Application No. 2,803,783, dated Jul. 7, 2016. |
Official Communication in Australian Application No. 2014277721, dated Sep. 8, 2016. |
Official Communication in Australian Application No. AU2012222229, dated May 11, 2016. |
Official Communication in Japanese Application No. JP 2013-555592, dated Aug. 8, 2016. |
Beaman, MD et al., “Substance P Innervation of Lumbar Spine Facet Joints”, Spine, 1993, vol. 18, No. 8, pp. 1044-1049. |
Butterman, et al., “An Experimental Method for Measuring Force on the Spinal Facet Joint: Description and Application of the Method”, Journal of Biomechanical Engineering, Nov. 1991, vol. 113, pp. 375-386. |
Cruess et al., “The Response of Articular Cartilage to Weight-Bearing Against Metal”, The Journal of Bone and Joint Surgery, Aug. 1984, vol. 66-B, No. 4, pp. 592-597. |
Dalldorf et al., “Rate of Degeneration of Human Acetabular Cartilage after Hemiarthroplasty”, The Journal of Bone and Joint Surgery, Jun. 1995, vol. 77. No. 6, pp. 877-882. |
Frost, Harold M., “From Wolff's Law to the Utah Paradigm: Insights About Bone Physiology and Its Clinical Applications”, The Anatomical Record, 2001, vol. 262, pp. 398-419. |
Kurtz, PhD et al., “Isoelastic Polyaryletheretherketone Implants for Total Joint Replacement”, PEEK Biomaterials Handbook, Ch. 14, 2012, pp. 221-226. |
Meisel et al., “Minimally Invasive Facet Restoration Implant for Chronic Lumbar Zygapophysial Pain: 1-Year Outcomes”, Annals of Surgical Innovation and Research (ASIR), 2014, vol. 8, No. 7, pp. 6. |
Panjabi, PhD et al., “Articular Facets of the Human Spine: Quantitative Three-Dimensional Anatomy”, Spine, 1993, vol. 18, No. 10, pp. 1298-1310. |
Ravikumar et al., “Internal Fixation Versus Hemiarthroplasty Versus Total Hip Arthroplasty for Displaced Subcapital Fractures of Femur—13 year Results of a Prospective Randomised Study”, International Journal of the Care of the Injured (Injury), 2000, vol. 31, pp. 793-797. |
Schendel et al., “Experimental Measurement of Ligament Force, Facet Force, and Segment Motion in the Human Lumbar Spine”, Journal of Biomechanics, 1993, vol. 26, No. 4/5, pp. 427-438. |
Sharpe Products, “Metal Round Disks”, https://web.archive.org/web/20170705214756/https://sharpeproducts.com/store/metal-round-disks, as archived Jul. 5, 2017 in 3 pages. |
Tanno et al., “Which Portion in a Facet is Specifically Affected by Articular Cartilage Degeneration with Aging in the Human Lumbar Zygapophysial Joint?”, Okajimas Folia Anatomica Japonica, May 2003, vol. 80, No. 1, pp. 29-34. |
Official Communication in Australian Application No. AU2016231622, dated Dec. 5, 2017. |
Official Communication in Canadian Application No. 2,803,783, dated Apr. 5, 2017. |
Official Communication in European Application No. 16180368.9, dated Mar. 31, 2017. |
Official Communication in European Application No. 16180368.9, dated Jan. 11, 2018. |
Official Communication in Australian Application No. 2014277721, dated Jan. 9, 2017. |
Official Communication in Canadian Application No. 2,804,223, dated Jun. 5, 2017. |
Official Communication in Canadian Application No. 2,804,223, dated Mar. 14, 2018. |
Official Communication in European Application No. 11818586.7, dated Feb. 3, 2017. |
Official Communication in Japanese Application No. 2015-242990, dated Dec. 12, 2016. |
Official Communication in Japanese Application No. 2015-242990, dated May 8, 2017. |
Official Communication in Japanese Application No. 2015-242990, dated Aug. 21, 2017. |
Official Communication in European Application No. EP12749447.4, dated Jan. 4, 2017. |
Official Communication in European Application No. EP12749447.4, dated Apr. 4, 2017. |
Official Communication in European Application No. 12749251.0, dated Jan. 4, 2017. |
Official Communication in European Application No. 12749251.0, dated May 9, 2017. |
Official Communication in Japanese Application No. 2016-246368, dated Oct. 30, 2017. |
Official Communication in Japanese Application No. JP 2013-555592, dated Jan. 5, 2018. |
Official Communication in Japanese Application No. 2016-237460, dated Oct. 23, 2017. |
Official Communication in Japanese Application No. 2016-237460, dated Apr. 16, 2018. |
Official Communication in Australian Application No. 2014241989, dated Aug. 31, 2017. |
Official Communication in European Application No. 14774714.1, dated Oct. 21, 2016. |
Official Communication in Japanese Application No. JP 2016-500490, dated Nov. 27, 2017. |
Official Communication in Japanese Application No. JP 2016-500490, dated May 7, 2018. |
Official Communication in Australian Application No. 2014241994, dated Oct. 30, 2017. |
Official Communication in European Application No. 14776445.0, dated Nov. 7, 2016. |
Official Communication in Japanese Application No. JP 2016-500498, dated Jan. 5, 2018. |
Official Communication in European Application No. 14850082.0, dated Aug. 31, 2016. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2015/050441, dated Mar. 30, 2017. |
International Preliminary Report on Patentability and Written Opinion in International Application No. PCT/US2016/013062, dated Aug. 10, 2017. |
Number | Date | Country | |
---|---|---|---|
20170000527 A1 | Jan 2017 | US |
Number | Date | Country | |
---|---|---|---|
61883911 | Sep 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14491820 | Sep 2014 | US |
Child | 15245664 | US |